Dr. Herkus - Company finances
- The company has not submitted financial data for these years: 2021.
|
EUR
|
2020
From: 2020-06-02
To: 2020-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | - | - | - | 1,671 | 24,282 |
| Profit before tax | 0 | 0 | 0 | 341 | 1,538 |
| Net profit | 0 | 0 | 0 | 324 | 1,446 |
| Equity | 0 | 0 | 0 | 0 | 1,538 |
| Liabilities | - | 0 | 0 | 0 | -92 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 |
| Current assets | 0 | 0 | 0 | 0 | 1,446 |
| Total assets | 0 | 0 | 0 | 0 | 1,446 |
|
Taxes paid
|
|||||
| STI taxes | - | - | - | - | 17 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | - | - | +1353.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | 100.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | 94.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | 19.4% | 6.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | 20.4% | 6.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dr. Herkus - Social security debts
The amount of overdue SODRA debt for the company Dr. Herkus as of the last working day is: 401 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-16 | 401.43 |
| 2026-09-01 | 2026-09-02 | 401.43 |
| 2026-08-26 | 2026-08-31 | 320.95 |
| 2026-08-23 | 2026-08-23 | 320.95 |
| 2026-08-19 | 2026-08-19 | 320.95 |
| 2026-08-16 | 2026-08-17 | 320.95 |
| 2026-08-01 | 2026-08-14 | 320.95 |
| 2026-07-23 | 2026-07-31 | 240.47 |
| 2026-07-01 | 2026-07-22 | 241.44 |
| 2026-06-02 | 2026-06-30 | 160.96 |
| 2026-05-03 | 2026-06-01 | 80.48 |
| 2026-04-27 | 2026-04-30 | 77.04 |
| 2026-04-10 | 2026-04-26 | 225.02 |
| 2026-04-01 | 2026-04-09 | 232.94 |
| 2026-03-03 | 2026-03-31 | 152.46 |
| 2026-02-03 | 2026-03-02 | 71.98 |
| 2023-11-03 | 2023-11-12 | 43.50 |
Dr. Herkus - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-19 | 2025-07-20 | 17.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dr. Herkus, MB is a Small partnership (code 305563888) engaged in retail sale of cosmetic and toilet articles. In the latest financial year, 2025, the company generated revenue of €24.3K and net profit of €1.4K, with a profit margin of 6.0%. Revenue increased sharply by 1353.1% year on year from €1.7K in 2024, while net profit rose from €324 to €1.4K over the same period. The margin was lower in 2025 than in 2024, reflecting faster top-line expansion than profit growth. At year-end 2025, total assets stood at €1.4K, equity at €1.5K, and reported liabilities at -€92, with short-term assets also at €1.4K. Profitability ratios were high, with ROE at 94.0% and ROA at 100.0%, and asset turnover reached 16.79x. The available figures indicate a business that expanded strongly in 2025, while operating with a very small balance sheet base.